Results 91 to 100 of about 1,758,994 (174)
Head and neck squamous cell carcinoma (HNSCC) is characterized by epidermal growth factor receptor (EGFR) overexpression, where EGFR levels correlate with survival.
Bhola, NE +9 more
core +1 more source
Neonatal gastrin-releasing peptide receptor blockade reduces maternal odor preference in rats
Alterations in attachment behavior might play a role in the dysfunction in social behavior displayed by autistic infants. Here we show that neonatal gastrin-releasing peptide receptor (GRPR) blockade induces a reduction in maternal odor preference, a ...
Dornelles, Arethuza da Silva +8 more
core +1 more source
Chronic itch is a major unmet problem that cannot be treated with anti-histamines. Itch information is relayed from the skin to the brain via the spinal cord. Previous studies show that systemic activation of classically Gαi-coupled -opioid receptor (KOR)
Munanairi, Admire
core +1 more source
The synthesis and preclinical evaluation of [(99m)Tc]Demomedin C in GRPR-expressing models are reported. Demomedin C resulted by coupling a Boc-protected N(4)-chelator to neuromedin C (human GRP(18-27)), which, after (99m)Tc-labeling, afforded [(99m)Tc ...
Theodosia Maina +11 more
core +1 more source
Gastrin-releasing peptide receptor (GRPR; GRP-R) [PDF]
openaire +1 more source
Yokoi, Hidenori +2 more
openaire +2 more sources
Itch is a sensation that promotes the desire to scratch, which can be evoked by mechanical and chemical stimuli. In the spinal cord, neurons expressing the gastrin-releasing peptide receptor (GRPR) have been identified as specific mediators of itch ...
Blumel, E (15673412) +6 more
core
Objective: This study aimed to verify the relation between gastrin-releasing peptide receptor (GRPR), oncogenic Human Papillomavirus (HPV) and cervical lesions severity.
Martina Lichtenfels +12 more
doaj +1 more source
Background: Bombesin shows high affinity for Gastrin-releasing peptide (GRP) receptors which over expressed on the cell surfaces of several human tumors particularly in prostate and breast cancers.
Nourollah sadeghzadeh +2 more
doaj

